Evozyne

Designs engineered protein therapeutics using an AI-native platform.

BiotechnologyArtificial Intelligence evozyne.com ↗

Company facts

Founded
2020
Employees
70
Headquarters
United States
Type
Private
Funding
Series B · $81M · 2023